<DOC>
	<DOCNO>NCT00675883</DOCNO>
	<brief_summary>A phase IV , observational , survey-based study measure compliance Avonex® PS therapy patient Relapsing-Remitting Multiple Sclerosis , compare persistence therapy 22 month initial prescription AVONEX® PS patient enrol current MS AllianceTM program versus patient enrol program prior October 2007 .</brief_summary>
	<brief_title>COMPliance With Avonex® PS Patients With Relapsing-Remitting MS</brief_title>
	<detailed_description>Study Design Five hundred patient enrol prospective portion study , receive AVONEX . Patients join study sign attach Informed Consent Form ( Appendix 1 ) doctor 's office time prescription . Innomar provide drug approximately 40 new patient per month , take twelve fourteen month enroll study subject , assume agree participate . Once recruitment period , take another 22 month complete study 22-months point last subject . In retrospective arm study , 500 chart review complete patient participate MS Alliance program two ( 2 ) three ( 3 ) year ago determine persistence therapy similar 22 month period . Study Objectives Primary Objectives : - To assess patient ' compliance ( define ) AVONEX therapy prospective arm use self-reported patient questionnaire , well compare patient ' persistence therapy ( define ) prospective retrospective arm . Secondary Objective : - Evaluate patient ' satisfaction new MSA program . Patients Methods Only patient enrol MSA program include study . There intervention current standard care MSA program . Two distinct patient arm exist study : prospective arm retrospective ( chart review ) arm . Inclusion Criteria - Diagnosed Relapsing Remitting Multiple Sclerosis ( RRMS ) - Prescription AVONEX® PS ( prefilled syrinx ) - Enrolment MS AllianceTM program</detailed_description>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<criteria>Diagnosed Relapsing Remitting Multiple Sclerosis ( RRMS ) Prescription AVONEX® PS ( prefilled syrinx ) Enrolment MS AllianceTM program</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>